Introduction {#s1}
============

The use of electron beams and X-rays generated by a particle accelerator (a machine source of radiation) has slightly increased in food irradiation and sterilization technology ([@r019]). A large proportion of industrial gamma irradiation may be replaced by the use of powerful electron accelerators, because of the lack of public acceptance and the inconvenience involved in the international trade in radioactive materials such as Cobalt-60 or Cecium-137, which are used to generate gamma rays ([@r006]). It is expected that X-ray radiation will be used more widely in food and sterilization industries due to its equivalent effectiveness on final products compared with gamma rays ([@r020]; [@r025], [@r024]). However, the low efficacy of the energy of X-ray irradiation should be improved for more practical and wider applications in industry ([@r003]).

The effects of ionizing energy on food compounds have been studied over wide ranges for various foods. Effects among the three radiation sources (gamma ray, electron beam, and X-ray) are not obviously different at the macroscopic level. However, at the microscopic level, food compounds are exposed directly to electrons during electron beam irradiation and this may induce different effects on food compounds, compared with gamma and X-ray irradiation ([@r023]; [@r024]). Therefore, a comparison study should be performed to understand the properties of reactions at the molecular level between food compounds and different sources of ionizing radiation.

In this study, isolated hen's egg albumin (ovalbumin, OVA) was used as a model protein to examine the differences between electron beam irradiation and X-ray irradiation in terms of conformational changes to OVA. OVA was selected because the structural changes caused by gamma irradiation have been relatively well explained in several studies ([@r010]; [@r011]; [@r017]), and these reports can be used as references in this comparison study between electron beam and X-ray irradiations. Turbidity at ultraviolet (UV) wavelengths, electrophoretic patterns on a sodium dodecyl polyacrylamide gel (SDS-PAGE), and immunological responses between antibody (Ab) and antigen (Ag) in competitive indirect enzyme-linked immunosorbent assay (Ci-ELISA) were measured to evaluate the differences in conformational changes to OVA induced by ionizing radiation that was generated by two radiation sources.

Materials and Methods {#s2}
=====================

Protein and antibodies {#s2a}
----------------------

OVA (purified from egg white) was purchased from Sigma Chemical Co. (USA) for use as the standard antigen. Mouse monoclonal Ab (M-IgG) and polyclonal Ab (P-IgG) for the testing of binding activity to OVA were purchased from LifeSpan Biosciences (USA). Horseradish peroxidase- (HRP-) conjugated rabbit anti-mouse IgG (Santa Cruz Biotechnology, USA) was used as a secondary Ab for M-IgG- and P-IgG-formatted Ci-ELISAs.

Preparation of OVA solution {#s2b}
---------------------------

OVA was dissolved in 0.01 M sodium phosphate-buffered saline (PBS) containing 0.15 M NaCl (pH 7.4) and adjusted to a final concentration of 2.0 mg/mL by comparing it with a standard protein solution prepared commercially. The concentrations of OVA solutions were determined by the bicinchoninic acid (BCA) method (Hill and Straka, 1988) using a BCA protein assay kit (Sigma Chemical Co.). Bovine serum albumin (BSA; Sigma Chemical Co.) solution (0.5-4.0 mg/mL) was used as a standard.

Electron beam and X-ray irradiations {#s2c}
------------------------------------

OVA solution (5 mL) was put into glass tubes (1 cm diameter). The tubes were placed horizontally onto plastic trays, tied with adhesive tape, and irradiated at the designated doses of 0 (control), 2, 4, 6, 8 and 10 kGy. Radiochromic film dosimetry with an area of 2 cm^2^ (Gafchormic^®^ HD-810, International Specialty Products, USA) was placed at the top and bottom of the tube (height of 1 cm) for each sample. Electron beam irradiation and X-ray irradiation were applied using an ELV-4 Electron-Beam- Accelerator (2.5 MeV) and an X-Ray Linear Accelerator (15 Kw, 5 MeV), respectively, at EB-Tech (EB-Tech Co., Korea). Optical densities (OD) of the dosimetry films were measured using a spectrophotometer at 560 nm and the actual absorbed doses were calculated by a method reported previously ([@r024]). After irradiation irradiation, the sample tubes were stored at 4℃ and used in subsequent experiments.

Determination of turbidity {#s2d}
--------------------------

Turbidity was measured with a spectrophotometer using a modification to the method of Chan *et al*. (1993) and Lee *et al*. (2000b). Irradiated OVA solutions (2.0 mg/mL) were placed in a quartz cuvette (1 cm light path length) and OD values were measured at 280, 320, 340, and 660 nm.

Gradient sodium dodecyl sulfate-polyacrylamide (SDS-PAGE) {#s2e}
---------------------------------------------------------

Samples of irradiated OVA solutions (2.0 mg/mL) were resolved by gradient SDS-PAGE (4-12% polyacrylamide gel) performed using Laemmli's method (1970). Staining and destaining of gels was performed using the method of Lee *et al*. (2000b). Destained gels were scanned using an image analysis system (Molecular Analyst with windows software for Bio-Rad, Version 1.5, 1992-1995, Bio Rad Pacific Ltd, USA) and OD values were presented as relative intensity. The ratio of the OD value of the irradiated OVA band to the OD of the non-irradiated OVA band was calculated to represent the relative band intensity percentage (%). A SeeBlue Plus2 Pre-stained standard marker was purchased from Invitrogen (USA) to determine the molecular masses of the protein bands. The standard protein marker contains 260, 160, 110, 80, 60, 50, 40, 30, 20, 15, 10, and 3.5 kDa standards.

Ci-ELISA {#s2f}
--------

Ci-ELISAs were individually formatted with M-IgG and P-IgG using previously reported methods (Kim *et al*., 2002; Lee *et al*., 2001) with slight modifications. Briefly, polystyrene flat-bottom microtiter plates (Maxisorp, Nunc, Denmark) were coated with 100 μL of non-irradiated OVA dissolved (10 μg/mL) in a 0.2 M bicarbonate buffer (pH 9.6), and incubated overnight at 4℃. The plates were washed three times with PBS containing 0.01% (v/v) Tween 20 (PBST). To reduce non-specific binding, the plates were blocked with 200 μL of PBS containing 2% (w/v) BSA. After washing, 50 μL samples of various concentrations (1.5, 3.1, 6.2, 12.5, 25.0, 50.0, and 100.0 μg/ mL) of the non-irradiated and irradiated (2, 4, 6, 8, and 10 kGy) OVA solutions were added to each well, and then 50 μL of M-IgG or P-IgG (LifeSpan Biosciences, USA) diluted in PBS (M-IgG: 640,000-fold, P-IgG: 80,000- fold) was added. The plates were incubated for 2 h, and then washed three times with PBST. To detect OVA binding to M-IgG or P-IgG on the well, 100 μL of HRP-conjugated goat anti-mouse IgG antibody (Santa Cruz Biotechnology) solution diluted 1:2,000 in PBS was added to each well and incubated for 1 h. The plates were then washed, and 100 μL of 3,3,5,5-tetramethylbenzidine (eBioscience, USA) substrate solution was added for 15 min to produce a color reaction, before stopping the reaction with 50 μL of 0.1 M H~2~SO~4~. The absorbance was measured at 450 nm using an ELISA plate reader (Varioskan Flash 3001, Thermo Scientific, USA).

Statistical analysis {#s2g}
--------------------

All samples were tested in triplicate, and the experiments were repeated five times. Means and standard deviations calculated from the equations for M-IgG and PIgG were used to evaluate the binding capacity (detected concentration) of OVA. Data obtained were analyzed by general linear procedures, least square means with limited standard deviations, and Duncan's multiple-range test as programmed by SAS^®^ software ([@r021]).

Results and Discussion {#s3}
======================

The changes of turbidity of OVA solutions {#s3a}
-----------------------------------------

Irradiated OVA solution (2.0 mg/mL) became increasingly turbid at increasing doses, regardless of radiation sources ([Table 1](#t001){ref-type="table"}). The increase in turbidity of irradiated OVA solution caused an increase in OD values at a low UV wavelength (≤360 nm). Exposure of hydrophobic residues of inner parts of the protein by a low radiation dose might increase the turbidity of the OVA solution ([@r007]; [@r018]). The structural release of susceptible parts in OVA might progress with irradiation at low doses of 2-4 kGy. At higher doses of 6 kGy and above, OVA might start to break down into polypeptides or become agglutinated, and then the native OVA could change into other molecules with new molecular weights and forms ([@r001]; [@r011]). This result is very similar to that reported in a previous study ([@r017]), which indicated that gamma-irradiated OVA solutions became increasingly turbid depending on the dose. [@r016] also reported an increase in turbidity of bovine myosin solution with gamma irradiation. Meanwhile, an increase in OD values at 280 nm can be misinterpreted as an increase in concentration of the protein. In the BCA assay, colorimetric changes were not observed in all samples. The result did not indicate changes in concentration but changes to the structure by ionizing radiation ([@r002]).

###### Changes in turbidity and colorimetric reaction by bicinchoninic acid assay of ovalbumin solution (2.0 mg/mL) irradiated by electron beam or X-ray

  Wavelength (nm)   Radiation source   Irradiation dose (kGy)                                                       
  ----------------- ------------------ ------------------------ ------------ ------------ ------------ ------------ -----------
  280               Electron beam      1.09*^a^*                1.52*^b^*    1.81*^c^*    1.98*^d^*    2.06*^e^*    2.10*^e^*
  X-ray             1.07*^a^*          1.51*^b^*                1.82*^c^*    1.93*^d^*    2.02*^e^*    2.09*^f^*    
  320               Electron beam      0.12*^a^*                0.26*^b^*    0.39*^c^*    0.51*^d^*    0.59*^de^*   0.67*^e^*
  X-ray             0.10*^a^*          0.26*^b^*                0.38*^c^*    0.49*^d^*    0.57*^e^*    0.68*^f^*    
  340               Electron beam      0.10*^a^*                0.19*^b^*    0.27*^bc^*   0.35*^c^*    0.39*^cd^*   0.45*^d^*
  X-ray             0.09*^a^*          0.19*^b^*                0.26*^bc^*   0.33*^c^*    0.38*^cd^*   0.45*^d^*    
  660               Electron beam      0.07                     0.07         0.06         0.07         0.07         0.07
  X-ray             0.06               0.07                     0.06         0.06         0.07         0.07         
  562^1)^           Electron beam      0.39                     0.38         0.39         0.39         0.40         0.39
  X-ray             0.39               0.39                     0.39         0.38         0.39         0.39         

^*a-f*^Different letters within a row with the same wavelength indicate significant differences (*p*\<0.05).

^1)^OD values of OVA solutions were measured by bicinchoninic acid assay based on the colorimetric reaction.

The changes in electrophoretic patterns {#s3b}
---------------------------------------

On SDS-PAGE, intact OVA showed two bands, a 43- kDa major band and its dimer at approximately 80 kDa ([Fig. 1](#f001){ref-type="fig"}). The change to OVA bands caused by electron beam or X-ray irradiation could be visually observed from 2 kGy in both irradiated samples. A band at 80 kDa and the major band (43 kDa) were not found in 2 kGy-irradiated samples and 4 kGy-irradiated samples, respectively. New bands were not observed, and traces of samples were smeared from the top of separating gels at doses of 4 kGy or more. However, the generation of new bands and traces was not shown in the lower molecular weight zone (\<80 kDa). Any visible differences between electron beam irradiation and X-ray irradiation were not evident on the gels. The relative band intensity (43 kDa) significantly decreased dependent upon the dose. The band intensities of OVA irradiated at 10 kGy by both forms of radiation decreased more than 90%, compared with the non-irradiated OVA band ([Fig. 1B](#f001){ref-type="fig"}). Several researchers have reported similar results for gamma-irradiated protein solutions, such as shrimp tropomyosin ([@r002]), milk proteins ([@r005]; [@r015]), bovine skeletal-muscle myosin ([@r016]), and egg proteins ([@r009]; [@r010]; [@r012]). However, this result appeared to be opposite to the result of [@r007]. By ionizing radiation, a protein molecule can be broken down to smaller molecules or aggregate to form larger molecules by interactions among the individual molecules ([@r012]; [@r013]). OVA became coagulated and formed very large aggregates after electron beam or X-ray irradiation in the presence of oxygen and at neutral pH condition (pH 7.4).

![**Electrophoretic patterns \[(A), gradient SDS-PAGE, 4-12% polyacrylamide gel\] and densitometric values \[(B), relative band intensity (%), irradiated OVA/non-irradiated OVA\] of OVA on gels.** M, prestained molecular weight marker; 0, 0 kGy; 2, 2 kGy; 4, 4 kGy; 6, 6 kGy; 8, 8 kGy; 10, 10 kGy.](kosfa-34-570-f001){#f001}

The changes in M-IgG- and P-IgG-binding capacities of OVA irradiated by electron beam or X-ray {#s3c}
----------------------------------------------------------------------------------------------

Changes in the binding capacity (detected concentration, μg/mL) of OVA for M-IgG or P-IgG in OVA solutions irradiated by electron beam or X-ray were observed by Ci-ELISA. [Fig. 2](#f002){ref-type="fig"} indicates the binding capacities of M-IgG against each OVA sample irradiated by electron beam or X-ray. The binding capacity of M-IgG increased towards 4-kGy electron beam-irradiated OVA (about 6.45 times), then decreased at higher doses. In X-ray-irradiated OVA samples, M-IgG recognized OVA irradiated at 2 kGy and above better than non-irradiated samples, and the binding capacity was strongest at 4 kGy with a reactivity of about 5.9 times. The binding capacity of M-IgG to X-ray-irradiated OVA decreased at doses higher than 6 kGy. However, differences were not statistically significant between 4 kGy and 8 kGy in electron beam-irradiated OVA and between 2 kGy and 6 kGy in X-ray-irradiated OVA (*p*\>0.05). M-IgG reacted with electron beam-irradiated OVA better than with X-ray-irradiated OVA. Statistically significant differences were observed between radiation sources for the binding capacity of M-IgG (*p*\<0.05).

![**Mouse murine monoclonal IgG-binding capacities (detected concentration, μg/mL) of each OVA sample irradiated by electron beam or X-ray.** The OVA concentrations were individually calculated using equations derived from standard curves obtained by Ci-ELISA formatted with the mouse murine monoclonal IgG against electron beam-irradiated OVA (Electron beam, ●) or X-ray-irradiated OVA (X-ray, ■ ).](kosfa-34-570-f002){#f002}

[Fig. 3](#f003){ref-type="fig"} indicates the binding capacities of P-IgG against each OVA sample irradiated by electron beam or X-ray. The binding capacity of P-IgG was higher for irradiated OVA samples than non-irradiated samples, regardless of radiation source. Binding capacity increased for 6-kGy electron beam-irradiated OVA with a reactivity of about 8.4 times, and then decreased at higher doses. In X-ray-irradiated OVA samples, P-IgG recognized OVA irradiated at 2 kGy and above better than non-irradiated samples, and the binding capacity increased in a dose-dependent manner. The reactivity was about 7.2 times at 10 kGy compared with non-irradiated OVA. However, no statistically significant difference was seen for samples between 2 kGy to 6 kGy in electron beam-irradiated OVA, and samples between 4 kGy to 8 kGy in X-ray-irradiated OVA (*p*\>0.05). The binding capacity of P-IgG to electron beamirradiated OVA was slightly higher than that of X-ray-irradiated OVA and the pattern of immune reaction was similar to that of M-IgG. However, changes in the doses of 4 to 10 kGy-irradiated OVA by X-ray showed differences compared with OVA irradiated by electron beam in the same dose range (*p*\>0.05). Unfortunately, the differences in immune responses of Ab to Ag (OVA) irradiated by different sources could not be explained in this study. The differences between radiation sources of immune reaction should be studied further.

![**Mouse polyclonal IgG-binding capacities (detected concentration, μg/mL) of each OVA sample irradiated by electron beam or X-ray.** The OVA concentrations were individually calculated using equations derived from standard curves obtained by Ci-ELISA formatted with the mouse polyclonal IgG against electron beam-irradiated OVA (Electron beam, ● ) or X-ray-irradiated OVA (X-ray, ■ ).](kosfa-34-570-f003){#f003}

OVA can be structurally altered by ionizing radiation, and its antigenicity can be changed. [@r009] and [@r010] reported the antigenicity (immune response of IgG) and allergenicity (immune response of IgE) of ovomucoid and OVA changed by gamma irradiation. The changes were not dependent upon the irradiation dose and showed a different pattern for antigenicity compared with allergenicity. [@r022], and Kume and Matsuda (2005) also reported the changes to conformational structures (epitopes) of gamma-irradiated OVA in their immunological studies. The conformational changes to OVA irradiated by electron beam or X-ray showed different reaction patterns in the mid-range of doses (\<10 kGy) in this study. This result indicates differences between radiation sources with respect to changes at the molecular level of a protein.

Conclusions {#s4}
===========

Electron beam irradiation and X-ray irradiation showed differences in the structural alterations of OVA by irradiation. Turbidity testing and electrophoretic patterns could not differentiate the differences between radiation sources in irradiated OVA samples. However, in Ci-ELISA, differences in conformational changes were observed between OVA samples irradiated by electron beam or X-ray. The result of these immunological responses indicates that one of the radiation sources should be evaluated and chosen by a preliminary study and a comprehensive molecular study conducted using ionizing radiation prior to general acceptance of the application
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